PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 51 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | -100.0% | 100 | -98.3% | 0.00% | – |
| Q2 2022 | $4,000 | 0.0% | 6,000 | +475.8% | 0.00% | – |
| Q1 2021 | $4,000 | -50.0% | 1,042 | -58.3% | 0.00% | – |
| Q4 2020 | $8,000 | +166.7% | 2,497 | +240.7% | 0.00% | – |
| Q3 2020 | $3,000 | -70.0% | 733 | -65.5% | 0.00% | – |
| Q2 2020 | $10,000 | -23.1% | 2,123 | -45.2% | 0.00% | – |
| Q1 2020 | $13,000 | -23.5% | 3,871 | +40.7% | 0.00% | – |
| Q4 2019 | $17,000 | +750.0% | 2,752 | +304.7% | 0.00% | – |
| Q3 2019 | $2,000 | -96.0% | 680 | -82.3% | 0.00% | – |
| Q2 2019 | $50,000 | -85.8% | 3,844 | -96.6% | 0.00% | – |
| Q4 2018 | $351,000 | – | 113,605 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 1,607,044 | $5,400,000 | 0.70% |
| NEA Management Company, LLC | 6,643,704 | $22,323,000 | 0.59% |
| DAFNA Capital Management LLC | 320,542 | $1,077,000 | 0.32% |
| Platform Technology Partners | 141,025 | $474,000 | 0.23% |
| Parkman Healthcare Partners LLC | 110,547 | $371,000 | 0.10% |
| Rock Springs Capital Management LP | 1,314,374 | $4,416,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 140,341 | $472,000 | 0.08% |
| SABBY MANAGEMENT, LLC | 65,000 | $218,000 | 0.04% |
| Virtu Financial LLC | 28,821 | $97,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 127,600 | $429,000 | 0.01% |